Navigation Links
Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline
Date:10/25/2011

al resources available to the company, is no longer tenable.

Background to Regulatory Process

In 2009, AMT filed Glybera for European marketing authorization "under exceptional circumstances". In Europe, this submission process is intended to allow drugs for extremely rare diseases to be approved, realizing that the clinical development package will never contain all the information that would be required for a more common condition.

The dossier was examined by the Committee for Advanced Therapies (CAT) and the CHMP, and in June 2011 both voted against approval of Glybera. AMT appealed the decision based on its interactions with representatives from the CHMP and two new CHMP Rapporteurs were appointed to lead the review process. During the appeal, both rapporteurs, an external scientific advisory group (SAG) consisting of European experts in the areas of gene therapy, lipid metabolism and pancreatitis, was appointed to review and analyze the data and to advise the EMA on its conclusions. The SAG concluded that Glybera should be approved under exceptional circumstances. Subsequently, the CAT performed its own analysis and also voted by a large majority in favor of Glybera marketing authorization. The advice from the SAG, the CAT and both the CHMP Rapporteurs, was provided to the CHMP. However, the CHMP did not change its previous opinion and again voted with the narrowest majority against Glybera marketing authorization. The Company has not yet been informed of the reasons for the CHMP decision.

Operations

Following a careful review of operations and resources needed for development of its remaining pipeline products, AMT management will work in close consultation with the works council to assess the impact of the review on the company's workforce. Management and board believe that for AMT to remain a viable business it needs to reduce the headcount by 50% to 45 full-time employees.

Financials

The measures announced to
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application
2. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
3. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
4. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
5. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
6. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
7. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
8. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
9. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
10. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
11. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- Neogen Corporation (NASDAQ: NEOG ) announced today ... May 31, increased 19% from the previous year to ... the prior year,s $27,190,000. Adjusted for a 3-for-2 stock ... the current year were $0.76, compared to $0.75 a ... 2014 fiscal year established new all-time highs for the ...
(Date:7/22/2014)... e SHENZHEN , Cina, 22 ... (BGI Tech), una filiale di BGI, la maggiore organizzazione ... di un nuovo servizio di sequenziamento dell,intero esoma umano ... Genomics. Complete Genomics, molto apprezzata nel ... sequenziamento proprietarie con il 99.999% di precisione e una ...
(Date:7/22/2014)... SHENZHEN, China , July 22, 2014 /PRNewswire/ ... a subsidiary of BGI, the world,s largest genomics ... new human whole exome sequencing service based on ... includes in-depth bioinformatics analysis and SNP validation, and ... 2014. Complete Genomics, highly regarded ...
(Date:7/22/2014)... In chemical and petrochemical plants, ... sight. The rapid rise of TDL analyzers over ... as a core gas measurement technology, and their ... the gas analyzer technology of choice for many ... some processes have limited their application range. METTLER ...
Breaking Biology Technology:Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... insurance premiums have increased approximately 113% over the past ... by the Kaiser Family Foundation, the reverse is true ... demonstrably cheaper over the past 25 years, due primarily ... competitive market pressures. In addition, many new enhancements to ...
... March 1, 2012 The second phase of ... Healthy Weight," is being announced today by the ... partnership with the Health Resources and Services Administration ... community leaders, from Pasadena to Philadelphia, have been ...
... 2012  AtheroNova Inc. (OTCBB: AHRO), a biotech company focused ... atherosclerotic plaque, today announced that it has initiated the ... its research and development partner CardioNova, Ltd., a Russia ... human clinical studies of AHRO-001. The clinical-grade material will ...
Cached Biology Technology:WestPark Capital's Michael Wechsler Comments on the Life Insurance Market 2Groundbreaking National Program to Reverse Obesity Expands to 50 Locations 2AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 2AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 3
(Date:7/23/2014)... The planet,s soil releases about 60 billion tons of ... more than that released by burning fossil fuels. This ... release of carbon is balanced by carbon coming into ... matter, as well as by the underground activities of ... that rising temperatures increase the rate of soil respiration. ...
(Date:7/23/2014)... in German . ... drive metabolic processes and transmit signals. To perform these ... at the Max Planck Institute for Developmental Biology in ... of similar amino acid chains even when their three-dimensional ... exist today arose from common precursors. Presumably, in the ...
(Date:7/23/2014)... megacephala is commonly found in dead bodies and ... of death, referred to as the post mortem interval. ... megacephala from Tamil Nadu is provided for the ... through generation of DNA barcoding. This study, significant in ... Biodiversity Data Journal . , Chrysomya megacephala ...
Breaking Biology News(10 mins):Climate change and the soil 2Protein evolution follows a modular principle 2Dead body feeding larvae useful in forensic investigations 2
... that snakes can optimize their vision by controlling the blood ... Kevin van Doorn, PhD, and Professor Jacob Sivak, from the ... blood flow patterns change depending on what,s in its environment. ... Journal of Experimental Biology . "Each species, perception ...
... If cats really had nine lives, one reason might be ... threaten feline health. Yunjeong Kim, a research assistant professor ... has developed a research approach that tackles two deadly infectious ... supported by a $156,342 award from the Morris Animal Foundation. ...
... Whitehead Institute scientists report that the gene mutated ... syndrome also prevents activation of mTORC1, a critical nutrient-sensing ... is an unexpected finding, as some cancers keep this ... expansion. In the case of Birt-Hogg-Dub syndrome, the mutated ...
Cached Biology News:Snakes control blood flow to aid vision 2College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 2College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 3Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway 2
[14C]Polyethylene glycol 4000, 9.25 MBq, 250 uCi. Aqueous solution containing 3% ethanol, sterilized. 370-740 MBq/g, 10-20 mCi/g.1.85 MBq/ml, 50 uCi/ml. Category: Radiochemicals &Radiation Safety, ...
... Complete kit for all types of ... , Choice of ... of self-activating baits , ... stringency , Complete ...
Mouse Limitin MAb (Clone 183727)...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: